Why AcelRx Is Jumping Despite FDA Update
AcelRx shares made a solid gain on Wednesday despite a less-than-favorable update from the FDA. However, there is a vote for approval on Friday. and that seems to be what investors are optimistic about.
AcelRx shares made a solid gain on Wednesday despite a less-than-favorable update from the FDA. However, there is a vote for approval on Friday. and that seems to be what investors are optimistic about.
The September 28 short interest data have been compared with the previous figures, and short interest in these selected big oil stocks increased.
Short interest in most of these selected social media stocks decreased as of the latest settlement date.
The September 28 short interest data have been compared with the previous figures, and short interest in these selected pharmaceutical stocks decreased.
The September 28 short interest data have been compared with the previous report. Short interest in these selected semiconductor stocks was mixed.
The September 28 short interest data have been compared with the previous figures, and short interest in most of these selected cybersecurity stocks decreased.
The September 28 short interest data have been compared with the previous figures, and short interest in most of these selected big bank stocks decreased.
The September 28 short interest data have been compared with the previous report, and short interest in most of the selected biotech stocks decreased.
Tuesday was a relatively flat day for the broad U.S. markets. The broad markets have been slowing down over the last few trading days as a result of increased strength in the bond markets.…
PPG Industries shares dropped on Tuesday after the company announced preliminary results for its third quarter. The expectations fell somewhat short, and inflation, as well as rising costs, are to blame for this.
Aurora Cannabis, one of the world's largest and leading cannabis companies, has filed with the SEC in preparation for its initial public offering.
Sears shares slid slightly after the company announced its newest addition to the board of directors, an advisor with experience in organizational change.
Mylan shares hit a 52-week low after Mapi Pharma announced midstage results from its multiple sclerosis trial.
Affimed shares took a big step back early on Tuesday after the company announced that it has placed its AFM11 on clinical hold, and has notified the global health authorities of its decision.
Papa John’s shares made a solid gain to kick off Tuesday after it was announced that an activist investor may be interested in the pizza chain.
Monday was a mixed day for the broad U.S. markets. At one point in the day, each of the major indices had a significant loss but each moved higher as the day went on.…
Akcea Therapeutics shares pulled back on Monday after the company announced a big change to its board of directors.
Exelixis shares dipped on Monday after the company announced that it has initiated a late-stage trial in patients with radioiodine-refractory differentiated thyroid cancer (DTC).
Starbucks shares didn’t react much despite the coffee giant announcing a big change at the top. The company is appointing a new CFO who will be taking over at the end of November.
A preview of Citigroup, Walgreens, Wells Fargo and some of the other major companies reporting their quarterly results this week.